Literature DB >> 16702088

Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation.

Stefano Masiero1, Chiara Briani, Rosario Marchese-Ragona, Paola Giacometti, Mario Costantini, Giovanni Zaninotto.   

Abstract

Cricopharyngeal myotomy is the most common treatment used to restore normal swallowing in patients with persistent (>6 months) cricopharyngeal muscle dysfunction post-stroke. We describe 2 patients whose dysphagia was due to cricopharyngeal muscle over-activity and who significantly improved after a percutaneous botulinum toxin injection in the cricopharyngeal muscle in combination with a rehabilitation treatment (dietary modifications, postural techniques, airflow protection manoeuvres). Swallowing was assessed clinically and by fibreoptic endoscopic evaluation of swallowing and videofluoroscopy; the degree of dysphagia was scored using the penetration-aspiration scale. Two months after the botulinum toxin injection the patients, who were previously fed via percutaneous endoscopic gastrostomy, returned to independent oral feeding and at 6, 12 and 24 months follow-up, both were still able to maintain an adequate oral intake with no signs of aspiration (by videofluoroscopy) or clinical complications. No further botulinum toxin injections or rehabilitation treatments were required. Our findings strongly suggest that even long-standing dysphagia can improve dramatically in selected patients. To the best of our knowledge, there are no other reports with such a long follow-up.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702088     DOI: 10.1080/16501970500515840

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  8 in total

1.  Speech pathologist practice patterns for evaluation and management of suspected cricopharyngeal dysfunction.

Authors:  Corinne A Jones; Molly A Knigge; Timothy M McCulloch
Journal:  Dysphagia       Date:  2014-02-06       Impact factor: 3.438

2.  Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia.

Authors:  Chiara Di Pede; Stefano Masiero; Valentina Bonsangue; Rosario Marchese Ragona; Alessandra Del Felice
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

3.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

Review 4.  Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.

Authors:  Pengxu Wei
Journal:  Toxins (Basel)       Date:  2022-04-30       Impact factor: 5.075

5.  Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.

Authors:  Elizabeth A Kelly; Ian J Koszewski; Safwan S Jaradeh; Albert L Merati; Joel H Blumin; Jonathan M Bock
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-02       Impact factor: 1.547

6.  The effects of botulinum toxin injections into the cricopharyngeus muscle of patients with cricopharyngeus dysfunction associated with pharyngo-laryngeal weakness.

Authors:  Virginie Woisard-Bassols; Sarah Alshehri; Marion Simonetta-Moreau
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-04       Impact factor: 2.503

7.  An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions.

Authors:  Ricardo Persaud; George Garas; Sanjeev Silva; Constantine Stamatoglou; Paul Chatrath; Kalpesh Patel
Journal:  JRSM Short Rep       Date:  2013-02-12

8.  Persistent post-stroke dysphagia treated with cricopharyngeal myotomy.

Authors:  Sruthi S Nair; Arathy Jalaja Surendaran; Jayakumar R Menon; Sapna Erat Sreedharan; Padmavathy N Sylaja
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.